Clene

+$0.07 (+3.17%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.

About CLNN

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.

CEO
Robert Dee Etherington
Employees
102
Headquarters
Salt Lake City, Utah
Founded
2013

CLNN Key Statistics

Market cap
144.22M
Price-Earnings ratio
8.19
Dividend yield
—
Average volume
134.54K
High today
$2.33
Low today
$2.11
Open price
$2.21
Volume
156.45K
52 Week high
$17.82
52 Week low
$1.93

CLNN Earnings

-$0.66
-$0.30
$0.06
$0.42
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure